Post-Pandemic Perspectives: Willingness, Risk Perception and Factors Influencing COVID-19 Booster Vaccine Uptake Among Thai Healthcare Workers and Vulnerable Populations.

Publication date: Dec 07, 2024

The emergence of new COVID-19 variants continues to affect healthcare workers (HCWs) and vulnerable populations in the post-pandemic era. This study aims to assess the willingness, perceptions, and factors associated with booster COVID-19 vaccine uptake in this context. A cross-sectional study was conducted between October 2023 and May 2024 among Thai adults (>20 years old) in Chiang Mai, Northern Thailand. Participants included HCWs and patients with chronic medical conditions. People who had received a monovalent XBB-derived booster vaccine were excluded. Data related to a total of 811 participants were analyzed, with 328 from the vulnerable group and 483 HCWs. Willingness to receive the booster was similar in both groups (43. 3% in HCWs, 45. 0% in the vulnerable group). Low-risk perception (59. 6%-83. 5%), minimal impact on daily life (60. 4%-62. 9%), and doubts about booster efficacy (75. 9%-81. 4%) were prevalent negative thoughts toward the booster. Having received a flu vaccine (aOR 2. 1), concerns about the impact on life of COVID-19 (aOR 1. 8), and beliefs in booster safety (aOR 1. 8) and vaccine effectiveness against severe disease (aOR 2. 7) were associated with increased willingness. Only 44% of participants were willing to receive a COVID-19 booster. Policymakers can use these insights to develop strategies to increase vaccine uptake in the post-pandemic era.

Open Access PDF

Concepts Keywords
Covid COVID-19 vaccine post-pandemic
October healthcare workers
Thailand high-risk groups
Vaccines risk perception
Workers Thailand

Semantics

Type Source Name
disease MESH COVID-19
disease MESH chronic conditions
disease MESH emergency
disease MESH viral load
drug DRUGBANK Coenzyme M
disease MESH morbidity
disease MESH infection
disease MESH long COVID
disease MESH complications
disease IDO history
disease MESH breakthrough infections
disease MESH endemic disease
disease IDO facility
disease MESH obesity
disease MESH lung disease
disease MESH asthma
pathway KEGG Asthma
disease MESH chronic kidney disease
disease MESH cardiovascular diseases
disease MESH cancer
disease MESH diabetes mellitus
disease MESH education level
disease MESH marital status
disease MESH hypertension
disease MESH high cholesterol levels
disease MESH cerebrovascular disease

Original Article

(Visited 1 times, 1 visits today)